Hyperfine Q2 revenue up 328% YoY to $1.5M; net loss $23.2M ($0.33/shr)

Hyperfine, Inc.

2022-Q2 EPS reported -$0.67 revenue$3,042,000

Revenue $1.533M (Q2 2022) vs $0.358M (Q2 2021); gross margin negative at ($0.165M).
Net loss $23.159M, $0.33 loss per share vs $8.80 loss per share in prior year.
Placed 9 commercial Swoop systems in Q2; total 20 YTD and 47 launch-to-date; installed base 92.
FY 2022 guidance: revenue $7-8M and 35-45 commercial unit installations expected.
Received FDA clearances for new deep-learning imaging sequences; partnered with Viz.ai for neuro ICU.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.